A nasal spray company wants to make it harder for the FTC to police health claims
1 min read
Summary
Utah-based Xlear, which manufactures a saline nasal spray, is suing the Federal Trade Commission (FTC) because it wants a court to limit the regulatory body’s ability to restrict health-related marketing claims.
Xlear was sued by the FTC in 2021 for making allegedly unsupported claims that its spray could help prevent COVID-19.
The Trump administration dropped the suit, and Xlear is now demanding its day in court.
Xlear’s legal offensive has coincided with a decline in government norms under the Biden and Trump administrations, which has included Health and Human Services Secretary Robert F. Kennedy Jr’s expulsion of the Centers for Disease Control and Prevention’s vaccine advisory board and Trump’s undermining of the FTC’s historic independence.
Xlear insists it is upholding high scientific standards in its marketing, but it wants the FTC held to an equally high legal one.